GMP Storage Market Set to Reach an Impressive US$ 10.2 Billion by 2032, Insights and Forecast by Persistence Market Research

The GMP (Good Manufacturing Practice) storage market is set for substantial growth over the next decade, with key developments in the pharmaceutical and biopharmaceutical industries driving demand for secure, temperature-controlled storage solutions. According to Persistence Market Research, the global GMP storage market was valued at approximately US$ 5.7 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 5.6%, reaching an estimated value of US$ 10.2 billion by 2032.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/33113

GMP storage is critical for maintaining the integrity and quality of pharmaceutical and biological products, particularly those that require stringent temperature control, such as vaccines and biologics. With increasing regulatory requirements and the rise of biologics and other temperature-sensitive products, the need for specialized GMP storage solutions is accelerating. The market is supported by advancements in storage technologies, growing biopharmaceutical production, and the need for compliance with international standards.

Key Market Statistics and Growth Drivers

The GMP storage market is being propelled by various growth drivers, including the increasing demand for biologics and biopharmaceuticals, the expansion of the vaccine market, and innovations in cold storage technologies. In 2021, the market accounted for a 4.7% revenue share of the global cold chain market, which was valued at US$ 119.98 billion. This market share is expected to grow steadily as the demand for temperature-sensitive pharmaceuticals and biopharmaceuticals continues to rise.

Key market statistics include:

Market Size (2022): US$ 5.9 billion

Projected Market Value (2032): US$ 10.2 billion

Global Market Growth Rate (2022-2032): 5.6% CAGR

Market Share of Top 5 Countries: 69.0%

The major drivers of this market include advancements in vaccine production, which requires precise temperature control, as well as innovations in cold storage technologies that offer better energy efficiency and improved performance. Moreover, regulatory compliance and increasing globalization in drug distribution networks are prompting biopharmaceutical companies to outsource GMP storage services to ensure their products meet international standards.

Leading Segment and Geographical Region

Among the various segments in the GMP storage market, biologics dominate as the leading application, accounting for around 38.0% of the market share in 2021. This dominance is primarily driven by the need to store temperature-sensitive biologics such as vaccines, blood plasma, and gene therapies. Biopharmaceutical companies require robust and compliant GMP storage solutions to protect these sensitive products and ensure their consistent quality.

In terms of geography, North America, particularly the U.S., is the leading region for GMP storage, accounting for over 89% of the market share in North America in 2021. This growth is largely due to the increasing number of FDA-approved temperature-sensitive drugs, which require stringent storage conditions. Moreover, the U.S. is home to numerous pharmaceutical and biotechnology companies, which further drives the demand for GMP storage solutions.

Key Highlights from the Report:

✦ The GMP storage market is expected to reach US$ 10.2 billion by 2032, growing at a CAGR of 5.6%.

✦ Biologics accounted for the largest market share of 38.0% in 2021.

✦ The U.S. dominates the North American GMP storage market with a market share of 89%.

✦ Technological advancements in cold storage are driving market growth, particularly energy-efficient solutions.

✦ Temperature-controlled GMP storage is increasingly outsourced by biopharmaceutical companies to enhance scalability.

✦ The European market is significantly influenced by Germany, which holds a major share in the region.

Market Segmentation

The GMP storage market is segmented based on product type, application, end-user, and service offerings. In terms of product types, the market is primarily divided into refrigerated and frozen storage solutions. These segments cater to the growing demand for temperature-sensitive drugs and biologics. Refrigerated storage is used for products that need to be kept at temperatures ranging from +2°C to +8°C, while frozen storage is required for products that need to be maintained at sub-zero temperatures.

In terms of applications, the GMP storage market is largely driven by biologics, which hold the largest market share due to their temperature-sensitive nature. Other applications include the storage of vaccines, blood components, and gene therapies. These products require strict temperature management to maintain their efficacy and safety.

End-users of GMP storage services include pharmaceutical manufacturers, biotechnology firms, and research organizations. The biopharmaceutical industry, in particular, has shown a high demand for outsourced GMP storage services, as these companies often require specialized storage solutions that comply with global regulations. Outsourcing allows them to scale operations quickly and efficiently without the significant capital investment required for building and maintaining their own storage facilities.

Regional Insights

The GMP storage market exhibits significant regional variations. North America is the dominant market, driven by the high concentration of pharmaceutical and biopharmaceutical companies in the U.S. The approval of new temperature-sensitive drugs by the U.S. FDA, such as vaccines and biologics, has contributed to the growth of the GMP storage market in the region. The U.S. also has stringent regulatory standards, further promoting the need for compliant storage solutions.

Europe is another key region, with Germany leading the market. Germany's strong biopharmaceutical industry, particularly in South Germany's BioPharma Cluster, contributes to the demand for GMP storage services. Additionally, the country's pharmaceutical firms are focusing on global expansion, which requires reliable and compliant storage solutions to ensure the integrity of products across different markets.

In Asia-Pacific, China is emerging as a significant player in the GMP storage market due to the country's rapid investments in biotechnology and life sciences. The Chinese government has committed substantial funding to support biopharmaceutical research and development, which has led to an increased need for GMP storage solutions in the country. China's growing biotech parks and innovation hubs further drive the demand for high-quality storage services.

Market Drivers

The GMP storage market is driven by several key factors, including advancements in biotechnology, the rising demand for biologics and vaccines, and the increasing complexity of pharmaceutical production. The demand for biologics has surged in recent years, with life-saving treatments such as gene therapies and monoclonal antibodies requiring specialized cold storage conditions to maintain product stability and efficacy.

The increasing prevalence of diseases and the need for more effective vaccines, such as those developed for COVID-19, have further amplified the demand for GMP storage services. The regulatory environment also plays a significant role, as pharmaceutical companies must adhere to stringent guidelines set by agencies such as the FDA and EMA, driving the need for compliant and reliable storage solutions.

Furthermore, the outsourcing trend in the pharmaceutical industry is expected to continue, as smaller companies and even large manufacturers seek cost-effective and flexible storage solutions without having to invest heavily in infrastructure.

Market Restraints

While the GMP storage market is experiencing robust growth, there are several challenges that could hinder its expansion. One of the primary obstacles is the high cost associated with establishing and maintaining temperature-controlled storage facilities. These facilities require significant investment in refrigeration systems, security measures, power backups, and skilled personnel for operation and maintenance.

Additionally, the cost of energy to maintain these storage conditions is another major challenge. As energy costs rise globally, maintaining temperature-sensitive storage becomes increasingly expensive, which could limit the profitability of some service providers.

Regulatory compliance also presents a challenge, as the constantly evolving standards in different countries can increase the complexity and cost of operations. Pharma companies must ensure their storage solutions are in line with both local and international regulations, which can be time-consuming and costly.

Market Opportunities

The GMP storage market is poised for growth in the coming years, fueled by several key opportunities. One significant opportunity lies in technological advancements, particularly in energy-efficient cold storage solutions. The development of smarter, more cost-effective refrigeration systems could reduce operational costs and increase the adoption of GMP storage services across various regions.

Another opportunity is the increasing demand for biopharmaceuticals, which requires specialized storage solutions. As the global demand for biologics, vaccines, and gene therapies rises, the need for high-quality GMP storage services will continue to grow.

Outsourcing GMP storage services presents an additional opportunity for growth. Many small- and medium-sized biopharmaceutical companies are increasingly turning to third-party storage providers to meet their regulatory requirements and scale their operations without incurring the high costs associated with setting up their own storage facilities.

Frequently Asked Questions (FAQs)

How Big is the GMP Storage Market?
Who are the Key Players in the Global GMP Storage Market?
What is the Projected Growth Rate of the GMP Storage Market?
What is the Market Forecast for the GMP Storage Market in 2032?
Which Region is Estimated to Dominate the GMP Storage Market through the Forecast Period?

Company Insights

• ThermoFisher Scientific
• Eppendorf AG
• BioLife Solutions, Inc.
• BioStorage Technologies, Inc.
• Catalent, Inc.

Recent Developments
In April 2021, BioLife Solutions, Inc. launched high-capacity controlled-rate freezers for the storage of biologics.

In March 2020, SY-Lab received EC Medical Device Certification for its innovative IceCube controlled rate freezers.

Conclusion

The GMP storage market is witnessing rapid growth, driven by the increasing demand for temperature-sensitive products and the need for compliance with strict regulatory standards. Technological advancements, along with the rise of biologics and vaccines, will continue to shape the future of this market. As biopharmaceutical companies increasingly rely on outsourced GMP storage services, the market presents significant opportunities for both established and emerging players in the cold chain logistics industry.

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.